Daily dose of inhaled steroids may not be necessary in mild-to-moderate asthma – Fox News


Mother Nature Network

Daily dose of inhaled steroids may not be necessary in mild-to-moderate asthma
Fox News
To treat asthma, doctors typically prescribe a daily dose of anti-inflammatory inhaled steroids, even when there are no symptoms present. The most current and widely used regimen includes a twice-a-day use of an inhaled corticosteroid coupled with the
Study Questions Daily Asthma MedsABC News (blog)
Asthma patients may not need daily steroidsMother Nature Network
Mild Asthma Patients May Do OK With Less SteroidsWebMD
NBCNews.com (blog) –UPI.com –U.S. News & World Report
all 84 news articles »

View full post on asthma – Google News

Montelukast versus inhaled corticosteroids in the management of pediatric mild … – 7thSpace Interactive (press release)

Montelukast versus inhaled corticosteroids in the management of pediatric mild
7thSpace Interactive (press release)
International guidelines recommend the use of inhaled corticosteroids (ICSs) as the preferred therapy, with leukotriene receptor antagonists (LTRAs) as an alternative, for the management of persistent asthma in children. Montelukast (MLK) is the first

View full post on asthma – Google News

Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled … – MarketWatch (press release)

Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled
MarketWatch (press release)
"We are strongly committed to advancing a pipeline of iCALM therapies to treat chronic respiratory diseases, including COPD, asthma and cystic fibrosis." "iCALM's ability to limit allergen-induced eosinophilic airway inflammation in this trial is

and more »

View full post on asthma – Google News

Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute … – Sacramento Bee

Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute
Sacramento Bee
One of these agents, R343, an inhaled SYK inhibitor, will be entering a Phase 2 clinical study later this summer in mild to moderate asthmatic patients. The other, R256, an inhaled IL13 signaling/JAK inhibitor, is potentially useful in controlling
Rigel moving asthma drug into mid-stage trialBizjournals.com (blog)

all 11 news articles »

View full post on asthma – Google News

Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute … – MarketWatch (press release)

Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute
MarketWatch (press release)
SOUTH SAN FRANCISCO, Calif., May 16, 2012 /PRNewswire via COMTEX/ — Rigel Pharmaceuticals, Inc., (NASDAQ:RIGL) is expanding its respiratory franchise by focusing on two innovative, comprehensive treatment alternatives for patients with asthma.

and more »

View full post on asthma – Google News

Inhaled Steroids Lead to Big Drop in Asthma Deaths at Texas Hospital: Study – U.S. News & World Report

Inhaled Steroids Lead to Big Drop in Asthma Deaths at Texas Hospital: Study
U.S. News & World Report
TUESDAY, May 15 (HealthDay News) — Patient education and medication compliance contributed to a 74 percent drop in the number of patients with life-threatening asthma admitted to the intensive care unit at University Hospital in San Antonio, Texas,
Asthma ICU hospital care declinesUPI.com

all 5 news articles »

View full post on asthma – Google News

Inhaled Beclomethasone Bests Fluticasone (Advair) When HIV PIs Being Used – AIDSmeds.com HIV/AIDS Treatment News

Inhaled Beclomethasone Bests Fluticasone (Advair) When HIV PIs Being Used
AIDSmeds.com HIV/AIDS Treatment News
by Tim Horn Good news for people living with HIV and asthma, bronchitis and chronic obstructive pulmonary disease (COPD). The inhalable steroid beclomethasone can be used at the same time as HIV protease inhibitors without the increased risk of adrenal

View full post on asthma – Google News